Filing Details
- Accession Number:
- 0001140361-12-025912
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-16 20:30:26
- Reporting Period:
- 2012-04-30
- Filing Date:
- 2012-05-16
- Accepted Time:
- 2012-05-16 19:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301173 | H Jeffrey Cooper | C/O Biomarin Pharmaceutical Inc. 10 Digital Drive Novato CA 94949 | Svp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-30 | 985 | $19.35 | 41,089 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 15,000 | $26.49 | 56,089 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 6,500 | $21.51 | 62,589 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 3,750 | $14.39 | 66,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-14 | 25,250 | $38.09 | 41,089 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2012-05-14 | 15,000 | $26.49 | 15,000 | $26.49 |
| Common Stock | Stock Option (right to buy) | Disposition | 2012-05-14 | 6,500 | $21.51 | 6,500 | $21.51 |
| Common Stock | Stock Option (right to buy) | Disposition | 2012-05-14 | 3,750 | $14.39 | 3,750 | $14.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 164,042 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
| 157,542 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
| 153,792 | 2009-11-12 | 2019-05-11 | No | 4 | M | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP period of November 1,2011 to April 30, 2012.
- Transaction made pursuant to a Rule 10b5-1 Trading plan executed March 6, 2012.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $37.31 to $38.6325. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vested 6/48ths on November 12, 2011 and 1/48th on the 12th of every month thereafter.
- Original option grant vested 6/48ths on November 12, 2010 and 1/48th on the 12th of every month thereafter.
- Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.
Billionaire Hedge Funds
